The Amazing Power of Black Pepper: Potential to Inhibit the Growth of Leukemia Cells

The Amazing Power of Black Pepper: Potential to Inhibit the Growth of Leukemia Cells

From the Dining Table's Black Pepper to Leukemia Research

The black pepper sprinkled on your dish as a finishing touch is now gaining attention as a subject of research for acute myeloid leukemia (AML), a type of blood cancer.

In August 2026, the academic journal 'Phytotherapy Research' published the results of cell and animal experiments using ethanol extracts of black pepper. A research team from Pontificia Universidad Javeriana in Colombia reported that the extract inhibited the proliferation of leukemia cells, reduced blood blasts in mice modeling AML, and extended their survival period.

Reading only the headlines might lead one to believe that "black pepper can be a medicine for leukemia." However, the study does not prove a therapeutic effect but marks the first step in the long journey of finding treatment candidates. Moreover, the pepper used in the experiments was not the same as the table pepper. It was a research-grade extract, concentrated from plant materials using 96% ethanol.

Because the results are promising, it is necessary to distinguish what is known and what remains unknown.


What is AML?

AML is a disease where immature myeloid cells abnormally proliferate in the bone marrow, which produces blood. These proliferated abnormal cells are called "blasts," and they take over the space where normal red blood cells, white blood cells, and platelets are produced. As a result, symptoms like anemia-induced shortness of breath, severe fatigue, infections, bleeding, and bruising become more likely.

As the name "acute" suggests, AML progresses rapidly, requiring swift evaluation and treatment after diagnosis. Treatment varies depending on the patient's age, overall condition, genetic mutations, and disease type, often combining chemotherapy, molecular targeted drugs, and hematopoietic stem cell transplantation.

While treatments have advanced, drug resistance and relapse remain significant challenges. Researchers are thus looking for new drugs targeting the mechanisms leukemia cells use to proliferate and survive, as well as auxiliary substances to aid existing treatments.


The "Cell Growth Switch" Targeted by the Research

The focus of this study was the PI3K/AKT/mTOR signaling pathway within cells. This pathway is one mechanism by which cells receive nutritional and growth signals, adjusting growth, metabolism, and survival.

While necessary for normal cells, it can be overactive in various cancers. In AML, the chronic activation of this pathway is thought to be related to leukemia cell survival, metabolic changes, and treatment resistance.

The research team investigated whether the black pepper extract induced changes related to this pathway. When the extract was added to cultured leukemia cells derived from mice, cell proliferation and survival decreased. Additionally, glucose uptake by the cells decreased at an early stage, and reactive oxygen species (ROS) increased.

Cancer cells require a large amount of energy and materials. Hindering glucose utilization and increasing oxidative stress could pose a dual burden on leukemia cells. However, the researchers themselves do not claim that the effects can be explained solely by the PI3K/AKT/mTOR pathway. Since plant extracts contain numerous components, multiple mechanisms might have been involved simultaneously.

Regarding molecules involved in immune evasion, the results were not uniform. While galectin-9 slightly decreased under certain conditions, no clear change was observed in PD-L1. Thus, rather than a simple conclusion of "completely stopping the targeted pathway," it should be viewed as a phenomenon where metabolism, oxidative stress, and immune modulation overlap.


What Happened in the Mice?

The research team injected leukemia cells that induce a condition similar to AML into mice to examine the effects of the black pepper extract. The comparison groups included an untreated group, a PI3K inhibitor group, and a group treated with the anticancer drug doxorubicin.

In mice administered with the black pepper extract, the proportion of blasts in the blood on the 12th day post-injection was lower than in the untreated group. Indicators such as neutrophils and lymphocytes also changed in a direction suggesting that normal hematopoiesis was somewhat maintained. Additionally, observations indicated a reduction in the burden of leukemia cells infiltrating the bone marrow and other areas, a decrease in inflammatory cytokines, and an increase in effector memory CD8-positive T cells.

The most straightforward figure is the survival period. The median for the untreated group was 25 days, compared to 35 days for the group administered with the extract. This is a significant difference in the mouse model and serves as a basis for proceeding to the next research phase.

However, the survival analysis involved eight mice per group, and some blood indicators were based on five mice per group due to blood sampling constraints. Human AML is extremely diverse in genetic abnormalities and disease conditions, but this experiment used a single model with specific mouse strains and leukemia cell lines. It cannot predict patient survival or treatment response from this.


"Eating Pepper" and "Administering Extract" Are Different Matters

This research cannot be directly translated into everyday life. Firstly, the experiment used a concentrated ethanol extract of black pepper, which differs in composition and concentration from the powder or grains used in cooking. Secondly, the dosage given to mice cannot be simply converted to human intake. Thirdly, which components reach the blood or bone marrow at what concentration after being absorbed in humans is unknown from this study.

Piperine is known as a representative component of black pepper, but the results cannot be attributed solely to piperine. The extract contains multiple compounds, and interactions between components might have influenced the results.

Moreover, the difference between food and supplements is crucial. The amount used in regular cooking is not the same as consuming high-concentration extracts in capsules or other forms. The term "plant-derived" does not guarantee safety. Supplements and herbs during cancer treatment can affect drug absorption, breakdown, and action. The U.S. National Cancer Institute also explains the potential for harmful outcomes due to interactions between cancer drugs and foods or supplements.

Therefore, patients should not increase their intake of pepper or piperine or alter prescribed treatments based on this study. If using or wanting to use supplements, it is necessary to inform the attending physician or pharmacist of the product name and content.


What Stands Out on Social Media is "Hope" and "Caution Against Overreach"

Public social media posts regarding this study have not yet sparked large-scale discussions, as far as can be confirmed. Therefore, it is not possible to indicate the number of reactions or the ratio of pros and cons. Instead of creating non-existent "voices from social media," organizing the recurring points in public posts or similar natural compound research can be divided into three main categories.

The first is the expectation that "finding new treatment candidates from familiar plants is hopeful." Research to find new targets and combination candidates for patients for whom existing drugs are less effective is important, and the observed extension of survival and changes in immune response are indeed worth further investigation.

The second is the cautious view that "what works in mice is different from what can treat humans." In cancer research, it is not uncommon for substances promising in cells or animals to fail to show sufficient effects in human clinical trials or for development to stop due to toxicity or absorption issues. If only the short headline "inhibits leukemia cells" spreads, the research stage can easily be overlooked.

The third is the caution against high-dose supplements based on self-judgment. The notion that "it's food, so trying it won't harm" is dangerous, especially for those using anticancer drugs, molecular targeted drugs, or immunosuppressants, where interaction checks are indispensable. When introducing research results on social media, it is necessary to highlight "unverified in humans," "not a substitute for standard treatment," and "extracts and foods are different" as prominently as the headline.


Research Needed Next

To advance as a treatment candidate, it is first necessary to clarify which components of the extract are active and what effects occur when components are combined. The composition of plant extracts can vary depending on the origin, harvest time, and extraction method. If it is to become a pharmaceutical candidate, standardization that can reproduce the same quality and effect each time is essential.

Next, reproducibility needs to be confirmed with multiple AML cell lines, patient-derived cells, and animal models with different genetic backgrounds. Toxicity to normal hematopoietic cells, effects on the liver and kidneys, safety during long-term administration, and interactions with existing drugs must also be investigated.

Beyond that, there are clinical trials involving humans. Initial trials first confirm safety, pharmacokinetics, and appropriate dosage. Progressing to comparative trials to evaluate efficacy comes after passing these stages. While the current paper mentions the potential for clinical application, there is no data at present demonstrating efficacy for AML patients.


What Truly Deserves Attention

The value of this research is not in the narrative that "eating black pepper can cure leukemia." It lies in the possibility that among the diverse chemical components plants possess, there may be clues that simultaneously target leukemia cell metabolism, proliferation, and immune evasion.

In the future, new drugs might be designed based on the identified active components rather than the extract itself. Alternatively, it could develop into adjunctive therapies that enhance the effects of existing treatments or reduce side effects. However, these are hypotheses to be verified in future research.

News linking familiar ingredients with serious diseases attracts strong interest. Therefore, it is crucial not to lose sight of whether the subject of "worked" refers to cultured cells, mice, or humans. The current findings are a seed of hope but not yet a treatment. Accurately conveying this distance is the first step to balancing expectations for research with patient safety.

※This article explains the research content and does not recommend diagnosis, treatment, or the use of supplements. Always consult your doctor or pharmacist regarding foods and supplements during treatment.


Source URL

Related Articles